为研究与调节免疫炎性应答的白细胞介素６（ＩＬ６）在ＤＩＣ中的血浆水平，以酶免疫法检测（ＥＩＡ）血浆ＩＬ６发现：ＤＩＣ病人血浆ＩＬ６水平明显高于非ＤＩＣ病人；ＤＩＣ合并脏器损伤的病例血浆ＩＬ６水平高于无脏器损伤病例；治疗反应较好的ＤＩＣ病人血浆ＩＬ６水平明显降低，与治疗反应差的存在明显差异。认为血浆ＩＬ６水平升高与ＤＩＣ和高凝状态有关；可作为ＤＩＣ合并脏器损伤和ＤＩＣ治疗、预后评价的一个指标。 For the study and regulation of immune inflammatory response of interleukin-6 (IL-6) plasma levels in DIC to enzyme immunoassay (EIA) plasma IL 6 found: DIC plasma IL 6 levels were significantly higher DIC patients; DIC combined with organ damage in plasma IL 6 levels higher than those without organ damage; DIC patients with better response to plasma IL 6 levels were significantly lower, and the difference was poor response to treatment. That elevated levels of plasma IL  6 and DIC and hypercoagulable state; DIC can be used as a combined organ injury and DIC treatment, an indicator of prognosis.